Tag: Ceryx Medical
Ceryx Medical to develop physiologically responsive pacemaker following funding boost
Ceryx Medical has announced the successful closure of a new funding round, bringing the company’s total raised to US$15 million, with the new investment...
First patient enrolled in trial of Cysoni temporary pacing technology
Ceryx Medical has announced that the first patient has been enrolled in the RSA-Pace multicentre study at Waikato Hospital in Hamilton, New Zealand evaluating...
Trial approved for new pacemaker aiming to boost recovery in heart...
Ceryx Medical has announced the approval of a trial evaluating Cysoni-XT—a new temporary cardiac pacemaker aiming to boost recovery in heart failure.
The UK Medicines...
RSA-pace study of Cysoni-XT temporary pacing system granted approval
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clinical trial authorisation application for the pilot respiratory sinus arrhythmia (RSA)-pace...
Ceryx Medical launches Cysoni bionic device for respiratory sinus arrhythmia
A collaboration between Ceryx Medical Limited and the scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, have developed...